Stay updated on Pembrolizumab SBRT in TKI mRCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab SBRT in TKI mRCC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new revision tag, v3.5.5, was added and the previous v3.5.4 tag removed, signaling an update to the study record.
    Difference
    0.1%
    Check dated 2026-06-05T11:03:29.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new revision tag, Revision: v3.5.4, was added and the previous Revision: v3.5.3 was removed. This is a metadata update to the page's revision history and does not modify the study information.
    Difference
    0.1%
    Check dated 2026-05-15T05:12:47.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s footer version label was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a non-content site update.
    Difference
    0.1%
    Check dated 2026-04-23T21:56:32.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T12:36:10.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T21:00:09.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. No changes visible in the study details content.
    Difference
    0.1%
    Check dated 2026-03-11T17:39:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab SBRT in TKI mRCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.